History of depression and other psychiatric illness as risk factors for Alzheimer disease in a twin sample

Alzheimer Disease and Associated Disorders

Volumn 13, Issue 1, 1999, Pages 47-52

  Wetherell, Julie Loebach ^a   Gatz, Margaret ^a   Johansson, Boo ^b   Pedersen, Nancy L ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b JÖNKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Aged; Alzheimer disease; Case control studies; Depression; Risk factors; Twins

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; RISK FACTOR; TWINS;

EID: 0032890691     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199903000-00007     Document Type: Article

References (33)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed., rev. Washington, DC: APA Press, 1987.
2. Barclay LL, Kheyfets S, Zemcov A, Blass JP, McDowell FH. Risk factors in Alzheimer's disease. In: Fisher A. Hanin I. Lachman C, eds. Alzheimer's and Parkinson's diseases. New York: Plenum, 1985; 141-6.
3. Berg S, Johansson B, Plomin R, Ahern FM, Pedersen NL, McClearn GE. Origins of variance in the old-old: the first presentation of the OCTO-twin study in Sweden [abstract]. Behav Genet 1992;22:708-9.
4. Breitner JCS, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994;44:227-32.
5. Breitner JCS, Silverman JM, Mohs RC, Davis KL. Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases and among male and female relatives in successive generations. Neurology 1988;38:207-12.
6. Broe GA, Henderson AS, Creasey H, et al. A case-control study of Alzheimer's disease in Australia. Neurology 1990;40:1698-1707.
7. Canadian Study of Health and Aging. The Canadian study of health and aging: risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-80.
8. Cox DR. Regression models and life-tables [with discussion]. J R Statist Soc B 1972;34:187-220.
9. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley & Sons, 1981.
10. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
11. French LR, Schuman LM, Mortimer JA, Hutton JT, Boatman RA, Christians B. A case-control study of dementia of the Alzheimer type. Am J Epidemiol 1985;121:414-21.
12. Gatz M, Pedersen NL, Berg S, et al. Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol Med Sci 1997; 52:M117-25.
13. Gatz M, Reynolds C, Nikolic J, Lowe B, Karel M, Pedersen N. An empirical test of telephone screening to identify potential dementia cases. Intl Psychogeriatr 1995;7:429-37.
14. Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984;15:335-41.
15. Jorm AF, Van Duijn CM, Chandra V, et al. Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Intl J Epidemiol 1991;20:S43-7.
16. Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ. Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 1991;41:1393-7.
17. La Rue A, Jarvik LF. Cognitive function and prediction of dementia in old age. Intl J Aging Hum Dev 1987;25:79-89.
18. Lipman RS, Brown EA, Silbert GA, et al. Cognitive performance as modified by age and ECT history. Prog Neuropsychopharmacol Biol Psychiatry 1993;17:581-94.
19. Liston EH, Jarvik LF, Gerson S. Depression in Alzheimer's disease: an overview of adrenergic and cholinergic mechanisms. Compr Psychiatry 1987;28:444-57.
20. Lykken DT, McGue M, Tellegen A. Recruitment bias in twin research: the rule of two-thirds reconsidered. Behav Genet 1987;17:343-62.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NTNCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
22. Mendez MF, Underwood KL, Zander BA, Mastri AR, Sung JH, Frey WH. Risk factors in Alzheimer's disease: a clinicopathologic study. Neurology 1992;42:770-5.
23. Minami Y, Tsuji I, Fukao A, et al. Physical status and dementia risk: a three-year prospective study in urban Japan. Intl J Soc Psychiatry 1995;41:47-54.
24. Morris JC, Heyman A, Mohs RC, et al. The consortium to establish a registry for Alzheimer's disease (CERAD): I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-65.
25. Ohm TG, Muller H, Braak H, Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 1995;64:20917.
26. Pedersen NL, McClearn GE, Plomin R, Nesselroade JR, Berg S, DeFaire U. The Swedish adoption/twin study of aging: an update. Acta Genet Med Gemellol 1991;40:7-20.
27. Reding M, Haycox J, Blass J. Depression in patients referred to a dementia clinic: a three-year prospective study. Arch Neurol 1985;42:894-6.
28. Rubin EH, Kinscherf DA, Figiel GS, Zorumski CF. The nature and time course of cognitive side effects during electroconvulsive therapy in the elderly. J Geriatr Psychiatr Neurol 1993;6:78-83.
29. SAS Institute Inc. SAS/STAT software: changes and enhancements through release 6.11. Cary, NC: SAS Institute, 1996.
30. Shalat SL, Seltzer B, Pidcock C, Baker EL. Risk factors for Alzheimer's disease: a case-control study. Neurology 1987;37:1630-3.
31. Speck CE, Kukull WA, Brenner DE, et al. History of depression as a risk factor for Alzheimer's disease. Epidemiology 1995;6:366-9.
32. Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Saunders AM, Breitner JC. A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biol Psychiatry 1997;41:851-6.
33. Van Duijn CM, Clayton DG, Chandra V, et al. Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies. Genet Epidemiol 1994;11:539-51.